CALR and thrombocytosis disease: Mice expressing human CALR mutations develop severe thrombocytosis and an approximately twofold increase in the number of BM megakaryocytes compared with WT mice, whereas mice expressing murine Calr mutations develop very mild thrombocytosis, with an ~1.3-fold increase in the number of BM megakaryocytes compared with WT mice.